Latest Breaking News On - Affinivax inc - Page 3 : comparemela.com

Axillary Hyperhidrosis Treatment Market is projected to exhibit a CAGR of 6 7%, and cross a worth of US$ 3 3 Billion by forecast ending 2033 | Future Market Insights, Inc

Axillary Hyperhidrosis Treatment Market is projected to exhibit a CAGR of 6 7%, and cross a worth of US$ 3 3 Billion by forecast ending 2033 | Future Market Insights, Inc
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew yorkRiemannas orklaDrug storesMarket insights incGreater new york chamberJourney medical corporation dermira incA look at related researchAuragen aestheticSientra incAffinivax incInnovation development trendsGlaxosmithkline plcFuture market insightMarket dynamics

Olaris Grows Leadership Team with Appointment of Dr Stuart Chaffee as Executive Chairman

Framingham, MA (PRWEB) September 26, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery and

Stuart chaffeeYale universityPolaris incCollege of williamAffinivax incAtlas ventureWharton schoolUniversity of pennsylvaniaElizabetho dayChief business officerChief financial officerPraxis precision medicinesBusiness operationsKymera therapeuticsSynthetic organic chemistryChief executive officer

GSK completes acquisition of Affinivax, Inc

GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines.

United statesUnited kingdomTony woodAffinivax incDrug administrationMultiple antigen presenting systemChief scientific officerBreakthrough therapyAnti trust improvements actAntigen presenting systemInfectious diseasesMedical specialtiesMerger and acquisitionPneumococcal conjugate vaccinePneumococcal infectionPneumococcal polysaccharide vaccine

GSK Concludes Acquisition Of Affinivax

LONDON (dpa-AFX) - GSK plc (GSK.L) on Tuesday said it has completed the acquisition of clinical-stage biopharmaceutical company Affinivax, Inc. The definitive deal was announced by GSK in May this

United statesCity ofUnited kingdomTony woodAffinivax incMultiple antigen presenting systemChief scientific officer

GSK completes acquisition of Affinivax

GSK completes acquisition of Affinivax

United statesUnited kingdomTony woodDrug administrationAffinivax incMultiple antigen presenting systemBreakthrough therapyAnti trust improvements actAntigen presenting systemChief scientific officer